These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9247723)
1. Urine glycosaminoglycan concentrations in mucopolysaccharidosis VI-affected cats following bone marrow transplantation or leukocyte infusion. Dial SM; Byrne T; Haskins M; Gasper PW; Rose B; Wenger DA; Thrall MA Clin Chim Acta; 1997 Jul; 263(1):1-14. PubMed ID: 9247723 [TBL] [Abstract][Full Text] [Related]
2. Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation. Gasper PW; Thrall MA; Wenger DA; Macy DW; Ham L; Dornsife RE; McBiles K; Quackenbush SL; Kesel ML; Gillette EL Nature; 1984 Nov 29-Dec 5; 312(5993):467-9. PubMed ID: 6438532 [TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6months of therapy in cats using different IV infusion durations. Ruane T; Haskins M; Cheng A; Wang P; Aguirre G; Knox VW; Qi Y; Tompkins T; O'Neill CA Mol Genet Metab; 2016 Feb; 117(2):157-63. PubMed ID: 26776148 [TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation in newborn rats with mucopolysaccharidosis type VI: biochemical, pathological, and clinical findings. Simonaro CM; Haskins ME; Kunieda T; Evans SM; Visser JW; Schuchman EH Transplantation; 1997 May; 63(10):1386-93. PubMed ID: 9175798 [TBL] [Abstract][Full Text] [Related]
5. Hepatic storage of glycosaminoglycans in feline and canine models of mucopolysaccharidoses I, VI, and VII. Haskins ME; Otis EJ; Hayden JE; Jezyk PF; Stramm L Vet Pathol; 1992 Mar; 29(2):112-9. PubMed ID: 1632054 [TBL] [Abstract][Full Text] [Related]
6. Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): a single dose of galsulfase further reduces urine glycosaminoglycans after hematopoietic stem cell transplantation. Whitley CB; Utz JR Mol Genet Metab; 2010 Dec; 101(4):346-8. PubMed ID: 20800524 [TBL] [Abstract][Full Text] [Related]
7. Bone changes in mucopolysaccharidosis VI in cats and the effects of bone marrow transplantation: mechanical testing of long bones. Norrdin RW; Simske SJ; Gaarde S; Schwardt JD; Thrall MA Bone; 1995 Nov; 17(5):485-9. PubMed ID: 8579961 [TBL] [Abstract][Full Text] [Related]
8. Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models. Entchev E; Jantzen I; Masson P; Bocart S; Bournique B; Luccarini JM; Bouchot A; Lacombe O; Junien JL; Broqua P; Tallandier M PLoS One; 2020; 15(5):e0233032. PubMed ID: 32413051 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation for feline mucopolysaccharidosis I. Ellinwood NM; Colle MA; Weil MA; Casal ML; Vite CH; Wiemelt S; Hasson CW; O'Malley TM; He X; Prociuk U; Verot L; Melniczek JR; Lannon A; Aguirre GD; Knox VW; Evans SM; Vanier MT; Schuchman EH; Walkley SU; Haskins ME Mol Genet Metab; 2007 Jul; 91(3):239-50. PubMed ID: 17482862 [TBL] [Abstract][Full Text] [Related]
10. Bone mineral density in feline mucopolysaccharidosis VI measured using dual-energy X-ray absorptiometry. Turner AS; Norrdin RW; Gaarde S; Connally HE; Thrall MA Calcif Tissue Int; 1995 Sep; 57(3):191-5. PubMed ID: 8574935 [TBL] [Abstract][Full Text] [Related]
11. Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation. Simonaro CM; Haskins ME; Abkowitz JL; Brooks DA; Hopwood JJ; Zhang J; Schuchman EH Gene Ther; 1999 Jan; 6(1):107-13. PubMed ID: 10341882 [TBL] [Abstract][Full Text] [Related]
12. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS. Byers S; Rozaklis T; Brumfield LK; Ranieri E; Hopwood JJ Mol Genet Metab; 1998 Dec; 65(4):282-90. PubMed ID: 9889015 [TBL] [Abstract][Full Text] [Related]
13. [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI]. Zheng J; Huang Y; Zhao X; Sheng H; Cheng J; Zhou Z; Li X; Mao X; Liu L Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):403-8. PubMed ID: 25190157 [TBL] [Abstract][Full Text] [Related]
14. Neonatal gene therapy with a gamma retroviral vector in mucopolysaccharidosis VI cats. Ponder KP; O'Malley TM; Wang P; O'Donnell PA; Traas AM; Knox VW; Aguirre GA; Ellinwood NM; Metcalf JA; Wang B; Parkinson-Lawrence EJ; Sleeper MM; Brooks DA; Hopwood JJ; Haskins ME Mol Ther; 2012 May; 20(5):898-907. PubMed ID: 22395531 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for mucopolysaccharidosis type VI is effective in cats without pre-existing immunity to AAV8. Ferla R; O'Malley T; Calcedo R; O'Donnell P; Wang P; Cotugno G; Claudiani P; Wilson JM; Haskins M; Auricchio A Hum Gene Ther; 2013 Feb; 24(2):163-9. PubMed ID: 23194248 [TBL] [Abstract][Full Text] [Related]
16. Pathology of the liver in mucopolysaccharidosis: light and electron microscopic assessment before and after bone marrow transplantation. Resnick JM; Krivit W; Snover DC; Kersey JH; Ramsay NK; Blazar BR; Whitley CB Bone Marrow Transplant; 1992 Sep; 10(3):273-80. PubMed ID: 1330150 [TBL] [Abstract][Full Text] [Related]
17. Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Swiedler SJ; Beck M; Bajbouj M; Giugliani R; Schwartz I; Harmatz P; Wraith JE; Roberts J; Ketteridge D; Hopwood JJ; Guffon N; Sá Miranda MC; Teles EL; Berger KI; Piscia-Nichols C Am J Med Genet A; 2005 Apr; 134A(2):144-50. PubMed ID: 15690405 [TBL] [Abstract][Full Text] [Related]
18. Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation. Krivit W; Pierpont ME; Ayaz K; Tsai M; Ramsay NK; Kersey JH; Weisdorf S; Sibley R; Snover D; McGovern MM N Engl J Med; 1984 Dec; 311(25):1606-11. PubMed ID: 6150438 [TBL] [Abstract][Full Text] [Related]
19. Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry. Crawley A; Ramsay SL; Byers S; Hopwood J; Meikle PJ Pediatr Res; 2004 Apr; 55(4):585-91. PubMed ID: 14711884 [TBL] [Abstract][Full Text] [Related]
20. Morphology of leukocytes from cats affected with alpha-mannosidosis and mucopolysaccharidosis VI (MPS VI). Alroy J; Freden GO; Goyal V; Raghavan SS; Schunk KL Vet Pathol; 1989 Jul; 26(4):294-302. PubMed ID: 2503918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]